PATENT CLAIM ANALYSIS

Application Number: 16161926
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["544", "333000"]

Abstract:
Disclosed are benzamide derivatives useful in slowing the expansion of cancer cells.

Claim (Index 36):
A method of synthesizing a pharmaceutical compound of formula 5 or formula 7, the method comprising: wherein R is selected from the group consisting of H, halo, \u2014C 1 -C 6  alkyl, aryl, \u2014C-C 7  cycloalkyl, and -3-to 10-membered heterocycle, wherein the \u2014C 1 -C 6  alkyl, aryl, \u2014C 3 -C 7  cycloalkyl, and -3- to 10-membered heterocycle may be unsubstituted or substituted; R\u2032 is \u2014C 3 -C 7  cycloalkyl substituted with \u2014C 1 -C 6  alkyl; and compound 9 is a \u2014C 3 -C 7  cycloalkylamine substituted with \u2014C 1 -C 6  alkyl with the proviso that only when R is an aromatic ring is the 2-fluoronitrobenzene of formula 1 prepared from the corresponding bromide of formula 8 through a Suzuki cross coupling reaction.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14733952', '13380213', '13813813', '12295967', '10719896']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7532009094471152
- 35 USC 102 Novelty (BERT): 0.4709445771248245
- Combined Prediction Score: 0.7249752762148861
- Mean Citation Score: 201.57804600000003
- Max Citation Score: 229.9136
- Similarity Product: 206.4486545043945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test